IL10 and cardiovascular disorder: Although S1008A was also viewed as inflammatory, emerging studies indicate that S1008A has anti-inflammatory effects through scavenging ROS, reducing oxidative damage, and promoting IL-10 expression [64], beneficial for the regression of cardiovascular diseases [65] and resolution of inflammation [66].